1,000 km against cancer: the Camino in 28 marathons

After beating cancer, Juan Pedro Orellana aims to complete the Via de la Plata from Jerez to Santiago de Compostela 1 to September 28

Fernando Borjas
30/08/2016 11:24
Itinerario 1.000 Km contra el cáncer (Vía de la Plata)

Itinerario 1.000 Km contra el cáncer (Vía de la Plata)

This Thursday September 1st begins in La Barca de la Florida (Jerez de la Frontera) the initiative 1,000 km against cancer, which aims to cover the distance that separates the Cadiz town from Santiago de Compostela in just 28 days, which equivalent to 28 marathons and all to raise funds for research into cancer stem cells.

The protagonist of this challenge is Juan Pedro Orellana, a runner who beat cancer and begin to participate in long distance races. Now the new challenge is to spend the next 28 days running the Via de la Plata, crossing Cadiz, Seville, Badajoz, Cáceres, Salamanca, Zamora, Tras-os-Montes e Alto Douro, Ourense, Pontevedra and A Coruña until he reaches his destination, although he will not be alone, because anyone can sign up to perform one of the stages of the initiative.

The initiative of Juan Pedro seeks on the one hand awareness of how necessary investment in stem cell research to fight cancer and on the other hand, raise funds for a research group at the University of Granada, led by professor Juan A. Marchal, head of the Chair Doctors Requena Galera and Stem Cell Research Carcinogens. Make a donation to the chair is very simple, you just have to enter this link.

Latest blog
Tips
Curiosities
La Voz de Galicia La Voz de Asturias

Points of interest

Cities & Towns | Hostels | Lodgings | Restaurants | Saddlery | Doctors | Points of interest | Bikes workshop

Contact us | Privacy policy | Cookies policy | | Terms of use | Authorship | Web Map | Consentimiento

© Copyright LA VOZ DE GALICIA S.A. Polígono de Sabón, Arteixo, A CORUÑA (ESPAÑA) Inscrita en el Registro Mercantil de A Coruña en el Tomo 2438 del Archivo, Sección General, a los folios 91 y siguientes, hoja C-2141. CIF: A-15000649

Developed and managed by Hyliacom